Listen "COVID-19 Progress: Pfizer’s U.S. Trials for Coronavirus Vaccine"
Episode Synopsis
Today, we're going to talk about legal issues in the COVID-19 vaccine development arena. A big challenge from a legal perspective is how can these companies get the vaccine to us? Typically when you're developing a new vaccine or anything for use inside of a human being, the FDA under the FD and C Act, the Federal Food, Drug and Cosmetics act, and the Public Health Service Act regulates the development of vaccines and anything that gets injected into your body. And there's a good reason for that and typically it takes a long time. These companies have to go through a series of clinical trials and they have to produce results to the FDA and the FDA has to come back, but there is a provision of the FD and C Act called an EUA, Emergency Use Authorization, and let's see if this happens. For the FDA to issue this EUA, which basically allows temporarily the use of an unapproved product, or an approved product for unapproved uses, the FDA has to go through the secretary of Health and Human Services. And the secretary of Health and Human Services have to first determine that there's a qualifying emergency caused by biological, chemical, radiological or nuclear. And here we've got, I think number one, biological emergency, COVID clearly. Two, the secretary of Health and Human Services has to find out that this agent can cause serious life threatening disease and the secretary then has to determine that for each product it's reasonable to believe that based on the totality of all the evidence available, that the product can treat or prevent the disease caused by this agent, in this case COVID, and that the known potential benefits outweigh the risk. Finally, that there are no other adequate and approved alternatives. So, in short, if COVID-19 is a biological qualifying emergency and the secretary of Health and Human Services finds that a company has produced something that it reasonably believes can help people, then it can issue this Emergency Use Authorization and we will get our vaccine. Let's wait and see what companies come up with, and the FDA comes up with. Hopefully they come up with it quickly. For more information check out this blog: https://www.dbllawyers.com/covid-19-progress-pfizer-inc-s-u-s-trials-for-coronavirus-vaccine/
More episodes of the podcast Blackletter
Exploring Securities Litigation
06/12/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.